A new anti-viral drug could improve COVID-19 outcomes and survival rates—and is highly effective against multiple variants—according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.
A new anti-viral drug could improve COVID-19 outcomes and survival rates—and is highly effective against multiple variants—according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.